- Report
- July 2026
- 150 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- April 2026
- 131 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- March 2026
- 135 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- March 2026
- 138 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- March 2026
- 132 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- December 2025
- 210 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- November 2025
- 210 Pages
Global
From €4489EUR$4,850USD£3,801GBP
- Report
- October 2025
- 96 Pages
Global
From €4165EUR$4,500USD£3,526GBP
- Report
- October 2025
- 83 Pages
Global
From €4165EUR$4,500USD£3,526GBP
- Report
- April 2026
- 90 Pages
Middle East
From €3656EUR$3,950USD£3,095GBP
- Report
- April 2026
- 109 Pages
United States
From €5507EUR$5,950USD£4,663GBP
- Report
- May 2026
- 180 Pages
United States
From €4396EUR$4,750USD£3,722GBP
- Report
- June 2026
- 70 Pages
United States
From €4396EUR$4,750USD£3,722GBP
- Report
- March 2026
- 150 Pages
United States
From €4489EUR$4,850USD£3,801GBP
- Report
- March 2026
- 150 Pages
United States
From €4489EUR$4,850USD£3,801GBP
- Report
- February 2026
- 240 Pages
United States
From €4489EUR$4,850USD£3,801GBP
- Report
- February 2026
- 361 Pages
United States
From €4489EUR$4,850USD£3,801GBP
- Report
- October 2026
United States
From €3693EUR$3,990USD£3,127GBP
- Report
- October 2026
Middle East
From €3693EUR$3,990USD£3,127GBP
- Report
- October 2026
Asia Pacific
From €3693EUR$3,990USD£3,127GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more